Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Global Monoclonal Antibody Diagnostic Reagents Competitive Landscape Professional Research Report 2024
... are designed to detect and identify specific antigens, molecules, or markers in biological samples for diagnostic purposes. Monoclonal antibody diagnostic reagents play a crucial role in various medical fields, including immunology, microbiology, hematology, and pathology. ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The single-use ... Read More
-
Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors , Vaccines , Growth Factors, and Other Product Types), By Technology (Irrational Protein Design and Rational Protein Design ), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Institutions, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Institutions, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Protein engineering is the process of developing useful proteins through rational ... Read More
-
Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material Type, Application - Global Forecast 2024-2030
... The Biopharmaceuticals Market size was estimated at USD 574.04 billion in 2023 and expected to reach USD 627.19 billion in 2024, at a CAGR 9.74% to reach USD 1,100.51 billion by 2030. Biopharmaceuticals, also known ... Read More
-
Antibody Drug Conjugate Market by Mechanism of Action (CD30 Antibodies, ErbB2 Antibodies), Drugs (Adcetris, Blenrep, Enhertu), Technology, Indication, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 16.12% to reach USD 15.96 billion by 2030. The antibody drug conjugate (ADC) includes developing, manufacturing, and commercializing therapeutic molecules ... Read More
-
Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030. The market for research antibodies refers to the global industry that revolves around ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 36.58 billion in 2024, at a CAGR 10.64% to reach USD 67.22 billion by 2030. Generic injectables are non-branded pharmaceuticals that are administered by injection and have the same ... Read More
-
Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030
... 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030. Research antibodies are proteins produced by the body's immune system to ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
HIV Vaccines Market by Phase (Phase I, Phase II, Phase III), Category (Preventive Vaccines, Therapeutic Vaccines), Antibodies, End Users - Global Forecast 2024-2030
... 2023 and expected to reach USD 940.05 million in 2024, at a CAGR 12.88% to reach USD 1,951.26 million by 2030. The HIV vaccine pertains to the research, development, and commercialization of vaccines that are ... Read More
-
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... CAGR of 7.20% during the period spanning 2024-2028. The growth in the market has been driven by factors like rising geriatric population, increasing prevalence of genetic disorders, government initiatives, rising demand for albumin, escalating use ... Read More
-
Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Intravenous Immunoglobulin market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Intravenous Immunoglobulin market report provides current treatment practices, emerging drugs, Intravenous ... Read More
-
Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Antibody-Mediated Graft Rejection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Antibody-Mediated Graft Rejection market report provides current ... Read More
-
ADC Contract Manufacturing Market (6th Edition)
... have emerged as a powerful therapeutic approach for treating a broad spectrum of cancers, encompassing both solid tumors and hematological malignancies. These sophisticated compounds consist of an antibody chemically linked to biologically active cytotoxic agents, ... Read More
-
Skeletal Dysplasia Drugs Market - By Dysplasia Type (Morquio A Syndrome, X-linked Hypophosphatemia, Hypophosphatasia, Achondroplasia), Treatment (Enzyme Replacement Therapy, Human Monoclonal Antibody), Distribution Channel – Global Forecast (2024 – 2032)
... is projected to witness 4.2% CAGR between 2024 and 2032 driven by the increasing prevalence and diagnosis of skeletal dysplasia. As per reports, non-lethal skeletal dysplasia occurs in approximately 1 in 26,000 to 1 in ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
CRISPR and Cas Genes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Product (Kits & Enzymes, Libraries, Design Tool, Antibodies, Others), Service (Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA synthesis)), By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations (CROs)), By Region and Competition, 2019-2029F
... Gene Editing, DNA synthesis)), By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations (CROs)), By Region and Competition, 2019-2029F Global CRISPR and Cas Genes Market was ... Read More
-
Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032
... By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032 The global cancer immunotherapy market size is expected to reach USD 261.39 billion by 2032 according to a new study by Polaris ... Read More
-
Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2024 - 2032
... Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2024 - 2032 The global active pharmaceutical ingredient (API) market size is expected to ... Read More
-
Oncology Biosimilars Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Monoclonal Antibodies, G-CSF, Hematopoietic Agents, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer, Cervical Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F
... Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F Global Oncology Biosimilars Market was valued at USD 3.27 Billion in 2023 and is anticipated ... Read More
-
France Antibody Drug Conjugates Contract Manufacturing Market Forecast 2024-2032
... growth, the rising demand for targeted therapies, the growing inclination towards contract manufacturing companies as an economical choice, the surging global cancer incidence, and advancements in drug conjugation technologies. MARKET INSIGHTS The France antibody drug ... Read More
-
Global Protein Therapeutics Market 2024-2028
... report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
China Antibody Drug Conjugates Contract Manufacturing Market Forecast 2024-2032
... growth, the rising demand for targeted therapies, the growing inclination towards contract manufacturing companies as an economical choice, the surging global cancer incidence, and advancements in drug conjugation technologies. MARKET INSIGHTS The China antibody drug ... Read More
Research Assistance
